Profile data is unavailable for this security.
About the company
Kubota Pharmaceutical Holdings Co., Ltd. is a Japan-based company mainly engaged in the operation and management of subsidiaries. Its subsidiaries are mainly engaged in discovering and developing drug candidates to treat and slow the progression of sight-threatening ophthalmic diseases. The Company operates pharmaceutical development segment. It focuses on the development of oral formulation for age-related macular degeneration (AMD), glaucoma and dry eye syndrome.
- Revenue in JPY (TTM)39.89m
- Net income in JPY-1.49bn
- Incorporated2015
- Employees12.00
- LocationKubota Pharmaceutical Holdings Co Ltd1-15-37, Minami-AoyamaMINATO-KU 107-0062JapanJPN
- Phone+81 365508928
- Fax+81 365508929
- Websitehttps://www.kubotaholdings.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Modalis Therapeutics Corp | 0.00 | -2.32bn | 2.76bn | 37.00 | -- | 2.53 | -- | -- | -72.46 | -72.46 | 0.00 | 29.59 | 0.00 | -- | -- | 0.00 | -103.95 | -29.19 | -112.89 | -30.02 | -- | -- | -- | -597.35 | 9.75 | -- | 0.2638 | -- | -100.00 | -- | 11.50 | -- | 135.50 | -- |
| Atect Corp | 3.20bn | 114.29m | 3.01bn | 96.00 | 26.27 | 1.43 | 6.54 | 0.9415 | 25.85 | 25.85 | 723.76 | 474.92 | 0.5713 | 3.22 | 6.85 | 33,330,020.00 | 2.04 | 2.03 | 2.83 | 2.78 | 44.68 | 47.69 | 3.57 | 3.84 | 0.7119 | -- | 0.546 | 29.40 | -4.03 | 2.10 | -6.37 | 14.01 | -23.31 | 0.00 |
| Muromachi Chemicals Inc | 6.12bn | 216.69m | 3.01bn | 205.00 | 13.77 | 1.39 | 8.58 | 0.4924 | 53.45 | 53.45 | 1,503.34 | 527.87 | 1.20 | 3.83 | 3.75 | 29,862,370.00 | 4.23 | -- | 6.84 | -- | 28.31 | -- | 3.54 | -- | 1.45 | 26.20 | 0.4483 | -- | 10.74 | -- | -43.83 | -- | -- | -- |
| Ribomic Inc | 62.64m | -979.09m | 3.07bn | 25.00 | -- | 0.8367 | -- | 48.96 | -27.45 | -27.45 | 1.76 | 100.39 | 0.0144 | -- | 1.22 | 2,505,440.00 | -22.56 | -32.10 | -24.05 | -33.30 | -- | -- | -1,563.14 | -1,688.50 | 18.53 | -- | 0.00 | -- | -18.47 | 0.3809 | 1.88 | -- | 10.04 | -- |
| D.Western Therapeutics Institute Inc | 428.36m | -812.41m | 3.45bn | 21.00 | -- | 2.69 | -- | 8.06 | -25.45 | -25.45 | 13.48 | 39.83 | 0.1607 | 0.4389 | 2.98 | 20,398,290.00 | -31.09 | -13.06 | -33.75 | -14.36 | 91.44 | 94.29 | -193.39 | -72.51 | 10.57 | -- | 0.4089 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| Kringle Pharma Inc | 70.58m | -865.79m | 3.54bn | 13.00 | -- | 1.44 | -- | 50.19 | -158.59 | -158.59 | 12.88 | 374.93 | 0.024 | -- | 0.7308 | 5,428,846.00 | -29.38 | -19.00 | -30.70 | -20.23 | -- | -- | -1,226.76 | -156.51 | 26.45 | -1,190.33 | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Human Metabolome Technologies Inc | 1.32bn | 282.64m | 3.79bn | 57.00 | 13.40 | 2.14 | 10.39 | 2.87 | 47.83 | 47.83 | 223.67 | 299.17 | 0.6302 | 14.23 | 4.74 | 23,186,330.00 | 13.48 | -- | 16.73 | -- | 65.03 | -- | 21.39 | -- | 4.27 | 151.90 | 0.1103 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
| OncoTherapy Science, Inc. | 901.22m | -1.19bn | 3.80bn | 60.00 | -- | 5.64 | -- | 4.22 | -5.77 | -5.77 | 4.36 | 3.01 | 0.7589 | 5.31 | 15.74 | 15,020,330.00 | -100.44 | -50.21 | -132.58 | -55.41 | -9.03 | -- | -132.35 | -331.97 | 3.29 | -258.18 | 0.00 | -- | -1.63 | 39.97 | 56.50 | -- | -57.92 | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 39.89m | -1.49bn | 3.88bn | 12.00 | -- | 1.46 | -- | 97.39 | -26.80 | -26.80 | 0.7175 | 47.21 | 0.0107 | 0.5317 | 14.77 | 3,323,917.00 | -40.06 | -36.51 | -43.86 | -39.47 | 70.48 | -- | -3,734.55 | -13,528.87 | 10.01 | -- | 0.0512 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
| FunPep Co Ltd | 530.00k | -933.42m | 4.08bn | 15.00 | -- | 1.65 | -- | 7,704.49 | -40.11 | -40.11 | 0.0225 | 94.97 | 0.0002 | -- | -- | 35,333.33 | -34.04 | -27.10 | -35.68 | -28.75 | -- | -- | -176,116.20 | -815.82 | 25.95 | -1,765.73 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| BrightPath Biotherapeutics Co Ltd | 118.00k | -1.21bn | 4.11bn | 32.00 | -- | 4.87 | -- | 34,869.45 | -19.27 | -19.27 | 0.0019 | 11.92 | 0.00007 | -- | 0.0423 | 3,687.50 | -71.34 | -42.65 | -89.42 | -44.49 | -433.05 | 57.16 | -1,028,827.00 | -4,430.66 | -- | -875.45 | 0.3929 | -- | -65.73 | -56.89 | -0.0971 | -- | -56.39 | -- |
| Perseus Proteomics Inc | 96.22m | -1.12bn | 4.14bn | 24.00 | -- | 2.56 | -- | 43.04 | -95.57 | -95.57 | 8.18 | 131.49 | 0.0424 | 1.82 | 11.22 | 4,009,083.00 | -49.52 | -33.51 | -51.65 | -34.95 | 89.01 | 93.09 | -1,168.66 | -470.63 | 17.58 | -- | 0.00 | -- | 30.96 | -20.89 | -31.38 | -- | 228.18 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 788.12m | -192.71m | 4.42bn | 60.00 | -- | 4.02 | -- | 5.61 | -20.69 | -20.69 | 84.62 | 118.02 | 0.5144 | 0.8788 | 3.78 | 13,135,280.00 | -12.58 | -15.11 | -14.85 | -17.61 | 62.06 | 56.66 | -24.45 | -50.04 | 3.49 | 0.494 | 0.1774 | -- | 22.71 | 0.9405 | -11.97 | -- | -- | -- |
| Renascience Inc | 191.32m | -331.66m | 4.44bn | 3.00 | -- | 2.70 | -- | 23.19 | -26.09 | -26.09 | 15.05 | 129.22 | 0.0851 | -- | -- | 63,772,000.00 | -14.74 | -- | -15.49 | -- | 85.75 | -- | -173.36 | -- | -- | -- | 0.1782 | -- | -27.84 | -- | -32.05 | -- | -- | -- |
| MEDRx Co Ltd | 29.53m | -932.90m | 4.94bn | 22.00 | -- | 2.35 | -- | 167.17 | -27.24 | -27.24 | 0.8492 | 50.17 | 0.0171 | 0.2606 | 1.22 | 1,342,455.00 | -54.07 | -58.15 | -58.45 | -62.23 | 91.87 | 95.70 | -3,158.72 | -1,526.17 | 17.75 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
| KAINOS Laboratories, Inc. | 5.06bn | 637.97m | 5.17bn | 144.00 | 7.43 | 0.7622 | 6.83 | 1.02 | 152.41 | 152.41 | 1,206.78 | 1,486.43 | 0.6053 | 3.08 | 4.55 | -- | 7.64 | 6.92 | 9.96 | 9.26 | 50.46 | 51.84 | 12.62 | 10.80 | 2.43 | -- | 0.1221 | 18.46 | 2.71 | 1.60 | 12.28 | 10.57 | -9.83 | 16.36 |
Data as of May 10 2024. Currency figures normalised to Kubota Pharmaceutical Holdings Co Ltd's reporting currency: Japanese Yen JPY
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Commons Asset Management, Inc.as of 19 Dec 2022 | 0.00 | 0.00% |
Data from 18 Jan 2023 - 18 Jan 2023Source: FactSet Research Systems Inc.
